STAT Pfizers abrupt withdrawal of sickle cell drug Oxbryta called tone deaf at ASH conference
| TNBRX Fund | USD 19.87 0.10 0.50% |
Slightly above 62% of 1290 Smartbeta's investor base is looking to short. The analysis of overall sentiment of trading 1290 Smartbeta Equity mutual fund suggests that many investors are alarmed at this time. 1290 Smartbeta's investing sentiment can be driven by a variety of factors including economic data, 1290 Smartbeta's earnings reports, geopolitical events, and overall market trends.
1290 |
Pfizers abrupt withdrawal of its sickle cell drug Oxybryta over safety concerns was called tone deaf
Read at statnews.com
 |
1290 Smartbeta Fundamental Analysis
We analyze 1290 Smartbeta's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 1290 Smartbeta using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 1290 Smartbeta based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Equity Positions Weight
Equity Positions Weight Comparative Analysis
1290 Smartbeta is currently under evaluation in equity positions weight among similar funds. Percentage of fund asset invested in equity instruments. About 80% of global funds and ETFs carry equity instruments on their balance sheet.
1290 Smartbeta Equity Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with 1290 Smartbeta mutual fund to make a market-neutral strategy. Peer analysis of 1290 Smartbeta could also be used in its relative valuation, which is a method of valuing 1290 Smartbeta by comparing valuation metrics with similar companies.
Peers
1290 Smartbeta Related Equities
| TNHIX | 1290 High | 0.23 | ||||
| MSTSX | Morningstar Unconstrained | 0.17 | ||||
| 70082LAB3 | 70082LAB3 | 0.18 | ||||
| LBHIX | Thrivent High | 0.23 | ||||
| RRTLX | T Rowe | 0.24 | ||||
| VIASP | Via Renewables | 0.40 | ||||
| TNVIX | 1290 Gamco | 0.84 | ||||
| SITKF | Sitka Gold | 3.85 |
Other Information on Investing in 1290 Mutual Fund
1290 Smartbeta financial ratios help investors to determine whether 1290 Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 1290 with respect to the benefits of owning 1290 Smartbeta security.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |